Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Differential expression of CD90 and CD14 stem cell markers in malignant breast cancer cell lines.

Lobba AR, Forni MF, Carreira AC, Sogayar MC.

Cytometry A. 2012 Dec;81(12):1084-91. doi: 10.1002/cyto.a.22220. Epub 2012 Oct 22.

2.

Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.

Louie E, Nik S, Chen JS, Schmidt M, Song B, Pacson C, Chen XF, Park S, Ju J, Chen EI.

Breast Cancer Res. 2010;12(6):R94. doi: 10.1186/bcr2773. Epub 2010 Nov 10.

3.

Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.

Jiang J, Zhang Y, Chuai S, Wang Z, Zheng D, Xu F, Zhang Y, Li C, Liang Y, Chen Z.

Oncogene. 2012 Feb 9;31(6):671-82. doi: 10.1038/onc.2011.282. Epub 2011 Jul 11.

PMID:
21743497
4.

High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.

Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess DA, Allan AL.

J Cell Mol Med. 2009 Aug;13(8B):2236-52. doi: 10.1111/j.1582-4934.2008.00455.x. Epub 2008 Aug 4.

5.

Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.

Fillmore CM, Kuperwasser C.

Breast Cancer Res. 2008;10(2):R25. doi: 10.1186/bcr1982. Epub 2008 Mar 26.

6.

Identification of local and circulating cancer stem cells in human liver cancer.

Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau CK, Li ML, Tam KH, Lam CT, Poon RT, Fan ST.

Hepatology. 2008 Mar;47(3):919-28. doi: 10.1002/hep.22082.

PMID:
18275073
7.

Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines.

Yan X, Luo H, Zhou X, Zhu B, Wang Y, Bian X.

Oncol Rep. 2013 Dec;30(6):2733-40. doi: 10.3892/or.2013.2784. Epub 2013 Oct 3.

PMID:
24101104
8.

Phenotypic characterization of retinoblastoma for the presence of putative cancer stem-like cell markers by flow cytometry.

Balla MM, Vemuganti GK, Kannabiran C, Honavar SG, Murthy R.

Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1506-14. doi: 10.1167/iovs.08-2356. Epub 2008 Nov 21.

PMID:
19029022
9.

The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.

Zia MK, Rmali KA, Watkins G, Mansel RE, Jiang WG.

Int J Mol Med. 2007 Oct;20(4):605-11.

PMID:
17786294
11.

Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.

Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS Jr, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI.

Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):19-29.

12.

Differentially expressed genes associated with the metastatic phenotype in breast cancer.

Kirschmann DA, Seftor EA, Nieva DR, Mariano EA, Hendrix MJ.

Breast Cancer Res Treat. 1999 May;55(2):127-36.

PMID:
10481940
13.

MicroRNA expression analysis of mammospheres cultured from human breast cancers.

Feifei N, Mingzhi Z, Yanyun Z, Huanle Z, Fang R, Mingzhu H, Mingzhi C, Yafei S, Fengchun Z.

J Cancer Res Clin Oncol. 2012 Nov;138(11):1937-44. doi: 10.1007/s00432-012-1272-5. Epub 2012 Jul 3.

PMID:
22752669
14.

Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.

Wang X, Liu Y, Zhou K, Zhang G, Wang F, Ren J.

Int J Clin Exp Pathol. 2015 May 1;8(5):5105-12. eCollection 2015.

15.

Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.

Won HY, Lee JY, Shin DH, Park JH, Nam JS, Kim HC, Kong G.

FASEB J. 2012 Dec;26(12):5002-13. doi: 10.1096/fj.12-209247. Epub 2012 Sep 5.

16.

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.

Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, Hur MH, Diebel ME, Monville F, Dutcher J, Brown M, Viens P, Xerri L, Bertucci F, Stassi G, Dontu G, Birnbaum D, Wicha MS.

Cancer Res. 2009 Feb 15;69(4):1302-13. doi: 10.1158/0008-5472.CAN-08-2741. Epub 2009 Feb 3.

17.

Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.

Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.

Clin Cancer Res. 2005 Jun 15;11(12):4357-64.

18.

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

19.

Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.

Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, Giacomantonio CA, Lee PW.

Stem Cells. 2011 Jan;29(1):32-45. doi: 10.1002/stem.563.

20.

Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.

Tomuleasa C, Soritau O, Rus-Ciuca D, Pop T, Todea D, Mosteanu O, Pintea B, Foris V, Susman S, Kacs├│ G, Irimie A.

J Gastrointestin Liver Dis. 2010 Mar;19(1):61-7.

Items per page

Supplemental Content

Write to the Help Desk